Literature DB >> 3819794

Measurement and interpretation of maximal oxygen uptake in patients with chronic cardiac or circulatory failure.

K T Weber, J S Janicki, D M Ward, P A McElroy.   

Abstract

Rapidly responding gas analyzers have simplified the monitoring of oxygen uptake (VO2) in the clinical exercise laboratory. An incremental, exhaustive, upright exercise test can be safely used to determine the plateau in oxygen uptake during exercise, or maximal VO2 (VO2max), in patients with chronic cardiac or circulatory failure. We define VO2max in these patients as an increase in VO2 of less than 1 ml/min/kg despite an increment in work load. The value for VO2max indicates the patient's aerobic capacity; it also predicts the maximal cardiac output during exercise and therefore serves as an estimate of cardiac reserve and of the severity of cardiac or circulatory failure. Symptom-limited VO2 during exercise, termed maximum oxygen uptake but more appropriately peak VO2, bears no relationship to VO2max. The two terms should not be used interchangeably.

Entities:  

Mesh:

Year:  1987        PMID: 3819794     DOI: 10.1007/bf00770881

Source DB:  PubMed          Journal:  J Clin Monit        ISSN: 0748-1977


  10 in total

1.  The physiological meaning of the maximal oxygen intake test.

Authors:  J H MITCHELL; B J SPROULE; C B CHAPMAN
Journal:  J Clin Invest       Date:  1958-04       Impact factor: 14.808

2.  Maximal oxygen intake as an objective measure of cardio-respiratory performance.

Authors:  H L TAYLOR; E BUSKIRK; A HENSCHEL
Journal:  J Appl Physiol       Date:  1955-07       Impact factor: 3.531

3.  Excercise physiology in health and disease.

Authors:  K Wasserman; B J Whipp
Journal:  Am Rev Respir Dis       Date:  1975-08

4.  On-line computer analysis and breath-by-breath graphical display of exercise function tests.

Authors:  W L Beaver; K Wasserman; B J Whipp
Journal:  J Appl Physiol       Date:  1973-01       Impact factor: 3.531

Review 5.  Anaerobic threshold and aerobic capacity in the evaluation of chronic cardiac or circulatory failure.

Authors:  K T Weber; J S Janicki
Journal:  Adv Cardiol       Date:  1986

6.  Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.

Authors:  K T Weber; V Andrews; J S Janicki; M Likoff; N Reichek
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

Review 7.  Quantification of exercise capability and evaluation of physical capacity in man.

Authors:  P O Astrand
Journal:  Prog Cardiovasc Dis       Date:  1976 Jul-Aug       Impact factor: 8.194

8.  Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.

Authors:  K T Weber; G T Kinasewitz; J S Janicki; A P Fishman
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

9.  Lactate production during maximal and submaximal exercise in patients with chronic heart failure.

Authors:  K T Weber; J S Janicki
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

10.  Cardiopulmonary exercise testing for evaluation of chronic cardiac failure.

Authors:  K T Weber; J S Janicki
Journal:  Am J Cardiol       Date:  1985-01-11       Impact factor: 2.778

  10 in total
  2 in total

1.  Peak oxygen uptake in relation to total heart volume discriminates heart failure patients from healthy volunteers and athletes.

Authors:  Henrik Engblom; Katarina Steding; Marcus Carlsson; Henrik Mosén; Bo Hedén; Torsten Buhre; Björn Ekmehag; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2010-12-16       Impact factor: 5.364

2.  Sub Maximal Ergospirometry Parameters in Untrained Non-Frail Octogenarian Subjects.

Authors:  Cristian Cofre-Bolados; Gerson Ferrari; Pedro Valdivia-Moral; Félix Vidal-Díaz; Robinson Ramírez-Vélez; Mikel Izquierdo-Redin
Journal:  Medicina (Kaunas)       Date:  2022-03-03       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.